PrimeRFP SCOUT · Federal Contract Recompete Brief

36C10X24D0028Incorporate vaar 852.204-72 personnel vetting — Fulgent Therapeutics LLC

Fulgent Therapeutics LLC holds $12.4M across 11 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 1 related award in the incumbent pipeline. Set-aside status: Unrestricted.

Sac Frederick (36C10X)
Awarding office
Fulgent Therapeutics LLC
Recipient
—
Estimated value
Q301
PSC
Unrestricted
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number36C10X24D0028
Also listed as36C10X-24-D-0028
AgencySac Frederick (36C10X)
Awarding officeSac Frederick (36C10X)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentFulgent Therapeutics LLC
UEIJVZDRESJLD82
PSCQ301
Related solicitation36C10X24R0051

Incorporate Vaar 852.204-72, Personnel Vetting and Credentialing (MARCH 2026)INCORPORATE FAR 52.222-90, Addressing Dei… is a federal Unrestricted award for Sac Frederick (36C10X) held by Fulgent Therapeutics LLC. Estimated value —. Related solicitation 36C10X24R0051.

Incorporate vaar 852.204-72, personnel vetting and credentialing (march 2026)incorporate far 52.222-90, addressing dei discrimination by federal contractors (april 2026). Latest action is a modification.

Want the durability read on 36C10X24D0028? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Fulgent Therapeutics LLC — $12.4M obligated across 11 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$12.4M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
36C10X26N0165
GERMLINE PGX MOLECULAR TESTING
$6.6M
Sep 29, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C10X24D0028?

36C10X24D0028 (Incorporate vaar 852.204-72 personnel vetting) is a Sac Frederick (36C10X) award with an estimated value of —, currently held by Fulgent Therapeutics LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C10X-24-D-0028?

36C10X-24-D-0028 is the dashed form of PIID 36C10X24D0028 (Incorporate vaar 852.204-72 personnel vetting), held by Fulgent Therapeutics LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C10X24D0028?

Sac Frederick (36C10X) awarded 36C10X24D0028 to Fulgent Therapeutics LLC.

Who is the incumbent on 36C10X24D0028?

Fulgent Therapeutics LLC is the incumbent with $12.4M across 11 related awards in SCOUT’s public footprint.

When does Fulgent Therapeutics LLC’s 36C10X24D0028 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C10X24D0028? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C10X24D0028